Blog

A group of UK research organisations, including the Wellcome Trust, have confirmed their support for genome editing techniques in preclinical human research, including in human reproductive cells and early embryos. Genome editing techniques such as CRISPR-Cas9, TALENs and zinc fingers, sometimes described as ‘molecular scissors’, allow targeted and efficient editing through precise removal and/or replacement […]

read more

The cross-disciplinary field of synthetic biology allows scientists to design and engineer organisms to carry out new roles, has been put to solving another challenge – that of creating a vaccine against the sexually transmitted disease chlamydia. Caused by an infection with the bacterium Chlamydia trachomatis,chlamydia is one of the most common sexually transmitted diseases […]

read more

One of the most satisfying things about working with early stage biotech ventures is helping start-ups execute on their ideas. At UK Innovation & Science Seed Fund we invest in scientists with ground breaking technology, who are highly capable on identifying applications but sometimes less familiar with the market and its commercial potential. These issues […]

read more

1 20 21 22 23 24 30